Japan Tissue Engineering Co., Ltd.
Tokyo Stock Exchange 7774.T
Japan Tissue Engineering Co., Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 129.85
-
Japan Tissue Engineering Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is 227.08 on April 09, 2024, which is 74.88% above the current Price to Earnings Ratio (P/E).
-
Japan Tissue Engineering Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is -33.71 on March 06, 2024, which is -125.96% below the current Price to Earnings Ratio (P/E).
-
Japan Tissue Engineering Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 123.23.
| Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
|---|
| CEO | Mr. Ken-Ichiro Hata D.D.S., Ph.D. |
| IPO Date | Dec. 28, 2007 |
| Location | Japan |
| Headquarters | 6-209-1 Miyakitadori |
| Employees | 211 |
| Sector | Health Care |
| Industries | |
Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in the development of cosmetics and drugs for external use, as well as in research that employs skin and cornea tissues. Further, the company offers regenerative medicine contract development and manufacturing services. The company was founded in 1999 and is headquartered in Gamagori, Japan. Japan Tissue Engineering Co., Ltd. is a subsidiary of Teijin Limited.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email